Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses

Filamentous fungal infections of the cornea: a global overview of epidemiology and drug sensitivity

(2015) László Kredics et al.   MYCOSES

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria

(2014) B. E. Ferro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Outbreak of Fungal Endophthalmitis Due to Fusarium oxysporum Following Cataract Surgery

(2014) Vladimír Buchta et al.   MYCOPATHOLOGIA

In Vitro Susceptibility of Filamentous Fungal Isolates From a Corneal Ulcer Clinical Trial

(2013) Prajna Lalitha et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles

(2013) Jan W. M. van der Linden et al.   CLINICAL INFECTIOUS DISEASES

Mycotic keratitis: epidemiology, diagnosis and management

(2013) P.A. Thomas et al.   CLINICAL MICROBIOLOGY AND INFECTION

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Schizophyllum commune: A New Organism in Eye Infection

(2013) Suman Saha et al.   MYCOPATHOLOGIA

Factors Affecting Treatment Outcomes With Voriconazole in Cases With Fungal Keratitis

(2012) Thushanthi Ramakrishnan et al.   CORNEA

Epidemiology ofAspergilluskeratitis at a tertiary care eye hospital in South India and antifungal susceptibilities of the causative agents

(2012) Palanisamy Manikandan et al.   MYCOSES

In VitroEchinocandin Susceptibility ofAspergillusIsolates from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

(2011) Shawn R. Lockhart et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cryptic Species and Azole Resistance in the Aspergillus niger Complex

(2011) Susan J. Howard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs

(2011) M. R. Shivaprakash et al.   MYCOSES

The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis

(2010) Y. Matsumoto et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Voriconazoleversusnatamycin as primary treatment in fungal corneal ulcers

(2010) Ritu Arora et al.   CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Ocular Fungal Infections

(2010) Ayse Kalkanci et al.   CURRENT EYE RESEARCH

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

(2010) Michael A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vitroactivity of nine antifungal agents against clinical isolates ofAspergillus calidoustus

(2010) Ana Alastruey-Izquierdo et al.   MEDICAL MYCOLOGY

Aspergillusspecies intrinsically resistant to antifungal agents

(2010) Jan W. M. Van Der Linden et al.   MEDICAL MYCOLOGY

Species Identification and Antifungal Susceptibility Patterns of Species Belonging to Aspergillus Section Nigri

(2009) L. Alcazar-Fuoli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Infectious Keratitis Caused by Aspergillus tubingensis

(2009) László Kredics et al.   CORNEA

Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints

(2009) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Mycotic Keratitis Due to Aspergillus nomius

(2009) P. Manikandan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

(2009) J. W. Baddley et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing

(2008) C. Lass-Florl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Voriconazole in the treatment of fungal eye infections: a review of current literature

(2008) S M Hariprasad et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Aspergillus calidoustussp. nov., Causative Agent of Human Infections Previously Assigned toAspergillus ustus

(2008) János Varga et al.   EUKARYOTIC CELL

Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis

(2008) R. E. Lewis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Development of Effective Ocular Preparations of Antifungal Agents

(2008) Indu Pal Kaur et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS